Endpoint | Coxnet | Gradient boost | ||||||
---|---|---|---|---|---|---|---|---|
Number of features | CCI train-set | CCI cross-valid | CCI test-set | Number of features | CCI train-set | CCI cross-valid | CCI test-set | |
Overall survival | 191 | 0.80 p < 0.005 | 0.52 ± 0.15 | 0.46 n.s | 22 | 0.99 p < 0.005 | 0.68 ± 0.13 | 0.45 n.s |
Disease free SV | 197 | 0.94 p < 0.005 | 0.54 ± 0.11 | 0.49 n.s | 10 | 0.97 p < 0.005 | 0.76 ± 0.09 | 0.52 n.s |
Local control | 199 | 0.77 p < 0.005 | 0.54 ± 0.24 | 0.36 n.s | 5 | 0.98 p < 0.005 | 0.89 ± 0.11 | 0.17 n.s |